Strategic Investments Propel Growth Amid …
This article first appeared on GuruFocus.
Release Date: November 05, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
-
Cencora Inc (NYSE:COR) reported a 16% growth in adjusted operating income and adjusted diluted EPS, driven by strategic investments and strong pharmaceutical utilization trends.
-
The company raised its long-term guidance for adjusted operating income growth to 6-9% and adjusted EPS growth to 9-13%, reflecting confidence in continued market growth.
-
Significant investments totaling $1 billion through 2030 are planned to enhance the distribution network, including a second national distribution center, to support customer growth and innovation.
-
The…
